Atrial Fibrillation

Stroke Patients Very Likely to Present with Undiagnosed Risk Factors
June 30, 2022

Three-quarters of stroke patients in a Swiss registry had at least 1 undiagnosed risk factor at the time of the event, most commonly hyperlipidemia or hypertension.

Novel FDA-cleared AFib History Software and Medication App Part of Newly Announced Apple Watch Update
June 13, 2022

Apple recently announced a new software release that will allow Apple Watch users access to health care-focused features and apps.

Black Patients with AF Often Don't Receive Anticoagulant at Hospital Discharge, Study Suggests
May 04, 2022

Black patients hospitalized with atrial fibrillation were 25% less likely to receive oral anticoagulants upon discharge according to a large national registry study.

FDA Clears Fitbit Algorithm to Detect Atrial Fibrillation
April 11, 2022

The FDA clearance for the FitBit algorithm will provide another widely tested tool for patient and clinicians to help identify arrhythmias earlier and avoid severe cardiocerebrovascular events.

Wearables for Cardio Monitoring May Yield Inaccurate Data Based on Skin Tone
March 30, 2022

ACC 2022. A new systematic review suggests skin melanin content may impede accurate recording of heart rate and rhythm by wearable devices.

Routine Point-of-Care Screening for Afib in Primary Care May Be Most Useful in Oldest Adults
March 07, 2022

Routine point-of-care AF screening in primary care using a handheld ECG device proved feasible but increased diagnoses only in patients aged ≥85 years, in the VITAL-AF study.

NOACs Linked to Lower Risk for Vascular Issues than Warfarin in Patients with Diabetes, Atrial Fibrillation
February 17, 2022

Researchers in Taiwan found NOACs were associated with lower hazards of diabetes complications. and death than warfarin in persons with AF and DM.

Burden of Atrial Fibrillation in Patients with Ischemic Stroke is Substantial According to New Study
February 11, 2022

Atrial fibrillation-related ischemic stroke may be a factor in hospital deaths among over 50% of older adults, suggests new findings presented at the International Stroke Conference.

USPSTF: Current Evidence Insufficient to Recommend For or Against Atrial Fibrillation Screening
January 28, 2022

In a new statement, the USPSTF determined current evidence is insufficient to recommend for or against screening for AF in older patients.

Aspirin Associated with Increased Risk for Incident Heart Failure in Large Patient-level Pooled Analysis
November 23, 2021

Treatment with aspirin of patients with cardiovascular risk factors was consistently associated with a greater than 25% risk of incident HF, another strike against the OTC antithrombotic.